Study points to new target for treating aggressive brain cancer

Researchers at The Ohio State University Comprehensive Cancer Center have identified SET as a promising therapeutic target for glioblastoma, one of the most lethal cancers. Glioblastoma tumors frequently resist standard radiation and chemotherapy treatments, making new approaches essential. This discovery could help make cancer cells more vulnerable to existing therapies, potentially improving outcomes for patients with this devastating disease. The finding represents a significant step toward developing more effective treatment strategies for this aggressive brain malignancy.